Apricus Biosciences develops commercial products and a broad pipeline across numerous therapeutic classes, generating revenues through its Apricus Pharmaceuticals USA and NexMed subsidiaries. Apricus currently markets the only product approved in the U.S. for the treatment of anthracycline extravasation. The company’s current pipeline includes Vitaros®, approved in Canada for erectile dysfunction, as well as compounds in development for sexual dysfunction, oncology, dermatology, autoimmune, pain, anti-infectives, diabetes, and consumer healthcare. For more information visit the company’s Web site at www.apricusbio.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com
Let us hear your thoughts below: